BD Unveils New FACSDiscover™ A8 Cell Analyzers to Advance Scientific Research and Flow Cytometry
- Becton Dickinson (BD) launches new three- and four-laser configurations of FACSDiscover™ A8 Cell Analyzers for enhanced research accessibility.
- BD's FACSDiscover™ A8 features advanced spectral and imaging technologies, enabling precise analysis of over 50 cell characteristics.
- BD aims to support scientific research by offering flexible, high-throughput automation and user-friendly software in its new models.
BD Launches New Configurations of FACSDiscover™ A8 Cell Analyzers to Empower Scientific Research
Becton, Dickinson and Company (BD) announces the global commercial release of new configurations for its BD FACSDiscover™ A8 Cell Analyzers, marking a significant advancement in the field of flow cytometry. The introduction of three- and four-laser models enhances accessibility for laboratories within academia, pharmaceuticals, and biotechnology sectors. These new configurations leverage advanced spectral and real-time imaging technologies, broadening the spectrum of research applications in areas such as immunology, cancer immunotherapy, and cell biology. As laboratories increasingly seek innovations that can elevate their research capabilities, BD's expanded offerings aim to meet the demand for high-resolution and sensitive cellular analysis.
The BD FACSDiscover™ A8 is equipped with BD SpectralFX™ Technology, enabling the analysis of over 50 characteristics of a single cell with remarkable precision. This feature is complemented by BD CellView™ Image Technology, which allows for rapid imaging and real-time spatial analysis of cellular components. These capabilities significantly enhance the potential for discoveries in complex biological systems. Additionally, the new configurations build on the previously launched five-laser model, providing scientists with a broader array of options to integrate cutting-edge technologies into their research workflows. The flexibility to start with a free trial of the CellView™ Image Technology and upgrade later via software offers laboratories a chance to adapt to the advanced tools at their own pace.
Gert Van Isterdael, head of VIB Flow Core Ghent, emphasizes the transformative nature of the BD FACSDiscover™ A8, noting its revolutionary impact on flow cytometry operations by integrating spectral and imaging data. This integration accelerates scientific understanding and opens avenues for discoveries that were previously unattainable. All configurations are designed with high-throughput automation and an intuitive software interface, enhancing both cost-effectiveness and user experience. By expanding the availability of these advanced technologies, BD aims to support a wider range of scientific research, empowering laboratories to derive better insights and drive advancements in their respective fields.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

